Renaissance Technologies’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-88,229
| Closed | -$40K | – | 4094 |
|
|
2024
Q1 | $40K | Buy |
88,229
+31,262
| +55% | +$14.2K | ﹤0.01% | 3517 |
|
|
2023
Q4 | $42K | Buy |
+56,967
| New | +$42K | ﹤0.01% | 3484 |
|
|
2023
Q3 | – | Sell |
-12,601
| Closed | -$24K | – | 4232 |
|
|
2023
Q2 | $24K | Buy |
12,601
+3,970
| +46% | +$7.56K | ﹤0.01% | 3744 |
|
|
2023
Q1 | $32K | Sell |
8,631
-5,630
| -39% | -$20.9K | ﹤0.01% | 3751 |
|
|
2022
Q4 | $54K | Sell |
14,261
-108
| -0.8% | -$409 | ﹤0.01% | 3783 |
|
|
2022
Q3 | $114K | Buy |
14,369
+2,412
| +20% | +$19.1K | ﹤0.01% | 3550 |
|
|
2022
Q2 | $251K | Buy |
11,957
+1,215
| +11% | +$25.5K | ﹤0.01% | 3546 |
|
|
2022
Q1 | $404K | Buy |
10,742
+4,623
| +76% | +$174K | ﹤0.01% | 3319 |
|
|
2021
Q4 | $344K | Sell |
6,119
-13,441
| -69% | -$756K | ﹤0.01% | 3274 |
|
|
2021
Q3 | $1.41M | Sell |
19,560
-1,683
| -8% | -$121K | ﹤0.01% | 2355 |
|
|
2021
Q2 | $2.04M | Buy |
21,243
+11,449
| +117% | +$1.1M | ﹤0.01% | 2253 |
|
|
2021
Q1 | $1.45M | Sell |
9,794
-11,325
| -54% | -$1.67M | ﹤0.01% | 2418 |
|
|
2020
Q4 | $2.95M | Sell |
21,119
-6,718
| -24% | -$939K | ﹤0.01% | 1905 |
|
|
2020
Q3 | $4.23M | Sell |
27,837
-16,967
| -38% | -$2.58M | ﹤0.01% | 1669 |
|
|
2020
Q2 | $7.87M | Buy |
44,804
+25,730
| +135% | +$4.52M | 0.01% | 1372 |
|
|
2020
Q1 | $2.72M | Buy |
19,074
+1,414
| +8% | +$201K | ﹤0.01% | 1895 |
|
|
2019
Q4 | $2.54M | Buy |
17,660
+4,784
| +37% | +$689K | ﹤0.01% | 2200 |
|
|
2019
Q3 | $1.29M | Buy |
12,876
+2,185
| +20% | +$218K | ﹤0.01% | 2492 |
|
|
2019
Q2 | $729K | Buy |
10,691
+2,271
| +27% | +$155K | ﹤0.01% | 2842 |
|
|
2019
Q1 | $379K | Buy |
8,420
+3,461
| +70% | +$156K | ﹤0.01% | 3031 |
|
|
2018
Q4 | $171K | Buy |
4,959
+1,105
| +29% | +$38.1K | ﹤0.01% | 3162 |
|
|
2018
Q3 | $285K | Buy |
3,854
+578
| +18% | +$42.7K | ﹤0.01% | 3033 |
|
|
2018
Q2 | $257K | Buy |
3,276
+420
| +15% | +$32.9K | ﹤0.01% | 3014 |
|
|
2018
Q1 | $251K | Buy |
2,856
+231
| +9% | +$20.3K | ﹤0.01% | 3129 |
|
|
2017
Q4 | $1.95M | Buy |
2,625
+654
| +33% | +$487K | ﹤0.01% | 2360 |
|
|
2017
Q3 | $568K | Buy |
1,971
+513
| +35% | +$148K | ﹤0.01% | 2759 |
|
|
2017
Q2 | $373K | Buy |
1,458
+884
| +154% | +$226K | ﹤0.01% | 2836 |
|
|
2017
Q1 | $191K | Buy |
574
+406
| +242% | +$135K | ﹤0.01% | 3007 |
|
|
2016
Q4 | $101K | Buy |
168
+41
| +32% | +$24.6K | ﹤0.01% | 3101 |
|
|
2016
Q3 | $143K | Buy |
127
+72
| +131% | +$81.1K | ﹤0.01% | 3130 |
|
|
2016
Q2 | $60K | Buy |
+55
| New | +$60K | ﹤0.01% | 3222 |
|